These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12649349)

  • 1. Low-molecular-weight fucoidan promotes therapeutic revascularization in a rat model of critical hindlimb ischemia.
    Luyt CE; Meddahi-Pellé A; Ho-Tin-Noe B; Colliec-Jouault S; Guezennec J; Louedec L; Prats H; Jacob MP; Osborne-Pellegrin M; Letourneur D; Michel JB
    J Pharmacol Exp Ther; 2003 Apr; 305(1):24-30. PubMed ID: 12649349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of fucoidan in myocardial ischemia.
    Manzo-Silberman S; Louedec L; Meilhac O; Letourneur D; Michel JB; Elmadbouh I
    J Cardiovasc Pharmacol; 2011 Dec; 58(6):626-32. PubMed ID: 22146406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.
    Fujita M; Ishihara M; Shimizu M; Obara K; Nakamura S; Kanatani Y; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
    Wound Repair Regen; 2007; 15(1):58-65. PubMed ID: 17244320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor.
    Lee M; Aoki M; Kondo T; Kobayashi K; Okumura K; Komori K; Murohara T
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2535-41. PubMed ID: 16224058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of middle molecular weight fucoidans on in vitro and ex vivo angiogenesis of endothelial cells.
    Matsubara K; Xue C; Zhao X; Mori M; Sugawara T; Hirata T
    Int J Mol Med; 2005 Apr; 15(4):695-9. PubMed ID: 15754034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of FGF-2 and VEGF-B in rabbits with bilateral hind limb ischemia.
    Wafai R; Tudor EM; Angus JA; Wright CE
    J Vasc Res; 2009; 46(1):45-54. PubMed ID: 18552506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
    Nakamura S; Nambu M; Ishizuka T; Hattori H; Kanatani Y; Takase B; Kishimoto S; Amano Y; Aoki H; Kiyosawa T; Ishihara M; Maehara T
    J Biomed Mater Res A; 2008 Jun; 85(3):619-27. PubMed ID: 17806115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
    Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia.
    Iwase T; Nagaya N; Fujii T; Itoh T; Ishibashi-Ueda H; Yamagishi M; Miyatake K; Matsumoto T; Kitamura S; Kangawa K
    Circulation; 2005 Jan; 111(3):356-62. PubMed ID: 15655128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model.
    Layman H; Sacasa M; Murphy AE; Murphy AM; Pham SM; Andreopoulos FM
    Acta Biomater; 2009 Jan; 5(1):230-9. PubMed ID: 18713669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia.
    Iwase T; Nagaya N; Fujii T; Itoh T; Murakami S; Matsumoto T; Kangawa K; Kitamura S
    Cardiovasc Res; 2005 Jun; 66(3):543-51. PubMed ID: 15914119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice.
    Oyama O; Sugimoto N; Qi X; Takuwa N; Mizugishi K; Koizumi J; Takuwa Y
    Cardiovasc Res; 2008 May; 78(2):301-7. PubMed ID: 18187460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis.
    Kondo K; Shintani S; Shibata R; Murakami H; Murakami R; Imaizumi M; Kitagawa Y; Murohara T
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):61-6. PubMed ID: 18974384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism.
    Carr AN; Howard BW; Yang HT; Eby-Wilkens E; Loos P; Varbanov A; Qu A; DeMuth JP; Davis MG; Proia A; Terjung RL; Peters KG
    Cardiovasc Res; 2006 Mar; 69(4):925-35. PubMed ID: 16409996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells.
    Zemani F; Benisvy D; Galy-Fauroux I; Lokajczyk A; Colliec-Jouault S; Uzan G; Fischer AM; Boisson-Vidal C
    Biochem Pharmacol; 2005 Oct; 70(8):1167-75. PubMed ID: 16153611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-resistant stromal cell-derived factor-1 for the treatment of experimental peripheral artery disease.
    Segers VF; Revin V; Wu W; Qiu H; Yan Z; Lee RT; Sandrasagra A
    Circulation; 2011 Mar; 123(12):1306-15. PubMed ID: 21403096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model.
    Deux JF; Meddahi-Pellé A; Le Blanche AF; Feldman LJ; Colliec-Jouault S; Brée F; Boudghène F; Michel JB; Letourneur D
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1604-9. PubMed ID: 12377737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hindlimb claudication reflects impaired nitric oxide-dependent revascularization after ischemia.
    Luque Contreras D; Jiménez Estrada I; Martínez Fong D; Segura B; Guadarrama JC; Paniagua Sierra R; Vargas Robles H; Rios A; Escalante B
    Vascul Pharmacol; 2007 Jan; 46(1):10-5. PubMed ID: 17011243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.